HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/4/C959    most recent 00153.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (15) Citing Articles via Google Scholar Google Scholar Articles by Cheng, J. Articles by Grande, J. P. Search for Related Content PubMed PubMed Citation Articles by Cheng, J. Articles by Grande, J. P.

RECEPTORS AND SIGNAL TRANSDUCTION

TGF-₁ stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process

¹Department of Laboratory Medicine and Pathology, and ²Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota

Submitted 1 April 2005 ; accepted in final form 26 May 2005

Monocyte chemoattractant protein-1 (MCP-1) and transforming growth factor (TGF)-₁ are critical mediators of renal injury by promoting excessive inflammation and extracellular matrix deposition, thereby contributing to progressive renal disease. In renal disease models, MCP-1 stimulates the production of TGF-₁. However, a potential role for TGF-₁ in the regulation of MCP-1 production by mesangial cells (MCs) has not previously been evaluated. The objectives of this study were to define the role of TGF-₁ in regulation of MCP-1 expression in cultured MCs and to define mechanisms through which rolipram (Rp), a phosphodiesterase isoenzyme 4 (PDE4) inhibitor with anti-inflammatory properties, alters MCP-1 expression. TGF-₁ induced MCP-1 in a time- and dose-dependent manner without increasing transcription of the MCP-1 gene. TGF-₁-mediated induction of MCP-1 occurred without activation of the NF-B pathway. Rp blocked TGF-₁-stimulated MCP-1 expression via a protein kinase A-dependent process, at least in part, by decreasing MCP-1 message stability. Rp exerted no effect on activation of the Smad pathway by TGF-₁. TGF-₁-mediated induction of MCP-1 required activation of ERK and p38, both of which were suppressed by a PDE4 inhibitor. TGF-₁-stimulated reactive oxygen species (ROS) generation by MCs, and Rp inhibited ROS generation in TGF-₁-stimulated MCs; in addition, both Rp and ROS scavengers blocked TGF-₁-stimulated MCP-1 expression. We conclude that TGF-₁ stimulates MCP-1 expression through pathways involving activation of ERK, p38, and ROS generation. Positive cross-talk between TGF-₁ and MCP-1 signaling in MCs may underlie the development of progressive renal disease. Rp, by preventing TGF-₁-stimulated MCP-1 production, may offer a therapeutic approach in retarding the progression of renal disease.

cAMP; inflammation; mitogen-activated protein kinase; reactive oxygen species

This article has been cited by other articles:

				E. Kolosionek, R. Savai, H. A. Ghofrani, N. Weissmann, A. Guenther, F. Grimminger, W. Seeger, G. A. Banat, R. T. Schermuly, and S. S. Pullamsetti Expression and Activity of Phosphodiesterase Isoforms during Epithelial Mesenchymal Transition: The Role of Phosphodiesterase 4 Mol. Biol. Cell, November 15, 2009; 20(22): 4751 - 4765. [Abstract] [Full Text] [PDF]

				R. A. Zager and A. C. M. Johnson Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1032 - F1041. [Abstract] [Full Text] [PDF]

				G. H. Tesch MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy Am J Physiol Renal Physiol, April 1, 2008; 294(4): F697 - F701. [Abstract] [Full Text] [PDF]

				Y. Kaneshiro, A. Ichihara, M. Sakoda, T. Takemitsu, A.H.M. N. Nabi, M. N. Uddin, T. Nakagawa, A. Nishiyama, F. Suzuki, T. Inagami, et al. Slowly Progressive, Angiotensin II-Independent Glomerulosclerosis in Human (Pro)renin Receptor-Transgenic Rats J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1789 - 1795. [Abstract] [Full Text] [PDF]

				N. S. Murali, A. W. Ackerman, A. J. Croatt, J. Cheng, J. P. Grande, S. L. Sutor, R. J. Bram, G. D. Bren, A. D. Badley, J. Alam, et al. Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease Am J Physiol Renal Physiol, February 1, 2007; 292(2): F837 - F844. [Abstract] [Full Text] [PDF]

				J. Cheng and J. P. Grande Cyclic Nucleotide Phosphodiesterase (PDE) Inhibitors: Novel Therapeutic Agents for Progressive Renal Disease Experimental Biology and Medicine, January 1, 2007; 232(1): 38 - 51. [Abstract] [Full Text] [PDF]

				Y. Ozawa, H. Kobori, Y. Suzaki, and L. G. Navar Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions Am J Physiol Renal Physiol, January 1, 2007; 292(1): F330 - F339. [Abstract] [Full Text] [PDF]

				J.-S. Kim, J.-G. Kim, M.-Y. Moon, C.-Y. Jeon, H.-Y. Won, H.-J. Kim, Y.-J. Jeon, J.-Y. Seo, J.-I. Kim, J. Kim, et al. Transforming growth factor-beta1 regulates macrophage migration via RhoA Blood, September 15, 2006; 108(6): 1821 - 1829. [Abstract] [Full Text] [PDF]